MoneyWorks4Me

Lupin informs about investors meet

11 Jan 2023 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A Para A(15) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed the investor presentation which will be made at the J. P Morgan Healthcare Conference, US on January 10, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..